Skip to main content

Optimi Health Corp.

OPTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002027329

No open-market purchases or sales by Optimi Health Corp. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $1.64M in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +10 vs. previous quarter
10
13F valueReported value at the end of Q2 2026
$1.64M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding OPTH, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding OPTH at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Optimi Health Corp. insiders from Form 4, newest first.

See all insider trades

No open-market purchases or sales by Optimi Health Corp. insiders are on file.

Top 10 13F holders, Q2 2026

The largest institutional positions in Optimi Health Corp. at the end of Q2 2026; share changes are against Q1 2026.

See all 10 holders
Institutions holding OPTH in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Yorkville Advisors Global, LP199,000$1.01M1.17%+199,000New
AdvisorShares Investments LLC102,794$523.2K0.06%+102,794New
Two Sigma Securities, LLC10,593$53.9K0.00%+10,593New
UBS Group AG5,872$29.9K0.00%+5,872New
Royal Bank of Canada1,964$10.0K0.00%+1,964New
National Bank of Canada598$3.06K0.00%+598New
TD Waterhouse Canada Inc.333$1.67K0.00%+333New
Mariner, LLC122,250$8370.00%+122,250New
Northwestern Mutual Wealth Management Co136$6920.00%+136New
SRS Capital Advisors, Inc.50$2540.00%+50New